Supernus to report Q1 2026 results on May 5, 2026 after market close

SUPERNUS PHARMACEUTICALS, INC.

Results announced after close May 5, 2026; conference call at 4:30 PM ET.
Call hosted by CEO Jack Khattar and CFO Tim Dec; Q&A session to follow.
Live webcast accessible via supernus.com/investors; replay available for 60 days.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SUPERNUS PHARMACEUTICALS, INC. reported financial results for first quarter of 2026.

Period: first quarter of 2026
Result: reported results

Exact text from the filing

On April 22, 2026, Supernus Pharmaceuticals, Inc. issued a press release announcing that it will report its business results for the first quarter of 2026 after the market closes on Tuesday, May 5, 2026.

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-26-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.